KR20110112381A - 색소 과다 침착의 치료용 조성물 및 치료 방법 - Google Patents

색소 과다 침착의 치료용 조성물 및 치료 방법 Download PDF

Info

Publication number
KR20110112381A
KR20110112381A KR1020117017755A KR20117017755A KR20110112381A KR 20110112381 A KR20110112381 A KR 20110112381A KR 1020117017755 A KR1020117017755 A KR 1020117017755A KR 20117017755 A KR20117017755 A KR 20117017755A KR 20110112381 A KR20110112381 A KR 20110112381A
Authority
KR
South Korea
Prior art keywords
skin
gly
gly gly
acid
positively charged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117017755A
Other languages
English (en)
Korean (ko)
Inventor
제이콥 엠. 워
Original Assignee
레반스 테라퓨틱스, 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 레반스 테라퓨틱스, 아이엔씨. filed Critical 레반스 테라퓨틱스, 아이엔씨.
Publication of KR20110112381A publication Critical patent/KR20110112381A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020117017755A 2008-12-31 2009-12-28 색소 과다 침착의 치료용 조성물 및 치료 방법 Ceased KR20110112381A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14209408P 2008-12-31 2008-12-31
US61/142,094 2008-12-31

Publications (1)

Publication Number Publication Date
KR20110112381A true KR20110112381A (ko) 2011-10-12

Family

ID=42285228

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117017755A Ceased KR20110112381A (ko) 2008-12-31 2009-12-28 색소 과다 침착의 치료용 조성물 및 치료 방법

Country Status (8)

Country Link
US (2) US20120014894A1 (cg-RX-API-DMAC7.html)
EP (1) EP2379177A1 (cg-RX-API-DMAC7.html)
JP (1) JP5836128B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110112381A (cg-RX-API-DMAC7.html)
CN (1) CN102292126B (cg-RX-API-DMAC7.html)
RU (1) RU2011125776A (cg-RX-API-DMAC7.html)
SG (1) SG172811A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010078244A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170077729A (ko) * 2015-12-28 2017-07-06 오비타트바이오팜 주식회사 TATdMt 펩타이드를 포함하는 미백 조성물
KR102206808B1 (ko) * 2019-09-05 2021-01-26 주식회사 에스스킨 신규한 세포-투과 펩타이드 및 이를 포함하는 피부 개선용 조성물
WO2024048890A1 (ko) * 2022-08-31 2024-03-07 주식회사 레메디 피부 미백 활성을 가지는 펩타이드를 포함하는 조성물

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
BRPI0508440A (pt) 2004-03-03 2007-07-24 Revance Therapeutics Inc composições e métodos para diagnóstico tópico e transporte terapêutico
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
CN104857514B (zh) * 2015-05-15 2018-01-19 东华大学 一种胰岛素脂质体透皮促进剂及其制备方法
KR102304280B1 (ko) 2018-08-14 2021-09-23 올리패스 주식회사 아세틸코에이카복실라제2 안티센스 올리고뉴클레오티드
BR112022005354A2 (pt) 2019-09-23 2022-08-23 Dds Res Inc Composições de vesícula lipídica com agentes potencializadores de penetração
CA3213099A1 (en) * 2021-03-24 2022-09-29 Robert A. Love Peptides and methods for reducing skin pigmentation
WO2025072381A1 (en) * 2023-09-25 2025-04-03 Revance Therapeutics, Inc. Methods for determining influence of carrier peptide on the binding of a therapeutic protein to a cell membrane

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6483010A (en) * 1987-09-25 1989-03-28 Sansho Seiyaku Kk Melanization inhibitory drug for external use
US6544548B1 (en) * 1999-09-13 2003-04-08 Keraplast Technologies, Ltd. Keratin-based powders and hydrogel for pharmaceutical applications
US6670322B2 (en) * 2000-06-01 2003-12-30 Wisconsin Alumni Research Foundation Method of targeting pharmaceuticals to motor neurons
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
US20040043463A1 (en) * 2002-09-03 2004-03-04 Pingfan Rao Peptide-tagged proteins and compositions for regulating features of the skin or hair; methods of making, and methods of using thereof
US20070154437A1 (en) * 2002-09-03 2007-07-05 Pingfan Rao Peptide-tagged proteins and methods of making and using thereof
HUE025656T2 (en) * 2004-03-03 2016-04-28 Revance Therapeutics Inc Topical application and transdermal delivery of botulinum toxins

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170077729A (ko) * 2015-12-28 2017-07-06 오비타트바이오팜 주식회사 TATdMt 펩타이드를 포함하는 미백 조성물
KR102206808B1 (ko) * 2019-09-05 2021-01-26 주식회사 에스스킨 신규한 세포-투과 펩타이드 및 이를 포함하는 피부 개선용 조성물
WO2024048890A1 (ko) * 2022-08-31 2024-03-07 주식회사 레메디 피부 미백 활성을 가지는 펩타이드를 포함하는 조성물

Also Published As

Publication number Publication date
US20100166689A1 (en) 2010-07-01
CN102292126B (zh) 2016-10-12
RU2011125776A (ru) 2013-02-10
CN102292126A (zh) 2011-12-21
US20120014894A1 (en) 2012-01-19
SG172811A1 (en) 2011-08-29
WO2010078244A1 (en) 2010-07-08
EP2379177A1 (en) 2011-10-26
JP5836128B2 (ja) 2015-12-24
JP2012514004A (ja) 2012-06-21

Similar Documents

Publication Publication Date Title
JP5836128B2 (ja) 色素過剰を治療するための組成物及び方法
JP2012514004A5 (cg-RX-API-DMAC7.html)
EP2316411B1 (en) Compositions comprising a skin-lightening resorcinol and a skin darkening agent
CN109998938B (zh) 一种用于美白亮肤淡斑的多肽组合物
CA2859419C (en) Cosmetic composition comprising an aqueous extract of navy-bean
JP6821866B2 (ja) 担体分子組成物および関連方法
US20250312265A1 (en) Crosslinked materials
JP6346962B2 (ja) 皮膚を水和させるための美容組成物
JP6416284B2 (ja) 刺激の低減された化粧品組成物
JP2019137695A (ja) 皮膚有効成分の浸透方法
US20160008241A1 (en) Powdered composition for use in the preparation of whitening cosmetic compositions
WO2012049453A2 (en) Compositions for topical applications
TATARINGA et al. Antirid peptides in cosmeceutical formula
Kimura Contact dermatitis caused by sunless tanning treatment with dihydroxyacetone in hairless descendants of Mexican hairless dogs
HK1165741B (en) Compositions and methods for treating hyperpigmentation
HK1165741A (en) Compositions and methods for treating hyperpigmentation
WO2026074302A1 (en) Collagen biovector comprising an anionic micelle-cationic polymer complex, cosmetic composition comprising the same, method for its preparation, and use thereof
ES2396582T3 (es) Nuevo péptido y composición cosmética y/o farmacéutica que lo contiene

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110728

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141229

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160211

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160922

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20160211

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I